TCA
Transcend Capital Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
57,536
-66,050
| -53% | -$1.6M | 0.11% | 172 |
|
|
2025
Q1 | $3.13M | Sell |
123,586
-28,283
| -19% | -$717K | 0.22% | 106 |
|
|
2024
Q4 | $4.03M | Sell |
151,869
-8,115
| -5% | -$215K | 0.29% | 81 |
|
|
2024
Q3 | $4.63M | Buy |
159,984
+5,216
| +3% | +$151K | 0.31% | 77 |
|
|
2024
Q2 | $4.33M | Buy |
154,768
+1,245
| +0.8% | +$34.8K | 0.31% | 71 |
|
|
2024
Q1 | $4.26M | Buy |
153,523
+32,246
| +27% | +$895K | 0.34% | 68 |
|
|
2023
Q4 | $3.49M | Buy |
121,277
+57,988
| +92% | +$1.67M | 0.31% | 75 |
|
|
2023
Q3 | $2.1M | Sell |
63,289
-6,157
| -9% | -$204K | 0.2% | 117 |
|
|
2023
Q2 | $2.55M | Buy |
69,446
+1,834
| +3% | +$67.3K | 0.24% | 98 |
|
|
2023
Q1 | $2.76M | Sell |
67,612
-1,871
| -3% | -$76.3K | 0.29% | 87 |
|
|
2022
Q4 | $3.56M | Sell |
69,483
-6,196
| -8% | -$317K | 0.39% | 58 |
|
|
2022
Q3 | $3.31M | Sell |
75,679
-1,063
| -1% | -$46.5K | 0.37% | 60 |
|
|
2022
Q2 | $4.02M | Buy |
76,742
+490
| +0.6% | +$25.7K | 0.42% | 52 |
|
|
2022
Q1 | $3.95M | Buy |
76,252
+6,061
| +9% | +$314K | 0.35% | 66 |
|
|
2021
Q4 | $4.15M | Buy |
70,191
+2,038
| +3% | +$120K | 0.37% | 68 |
|
|
2021
Q3 | $2.97M | Buy |
68,153
+628
| +0.9% | +$27.4K | 0.27% | 98 |
|
|
2021
Q2 | $2.65M | Buy |
67,525
+4,047
| +6% | +$159K | 0.38% | 69 |
|
|
2021
Q1 | $2.3M | Buy |
63,478
+748
| +1% | +$27.1K | 0.28% | 93 |
|
|
2020
Q4 | $2.31M | Sell |
62,730
-45,958
| -42% | -$1.69M | 0.3% | 89 |
|
|
2020
Q3 | $3.99M | Buy |
108,688
+26,348
| +32% | +$967K | 0.73% | 28 |
|
|
2020
Q2 | $2.69M | Sell |
82,340
-7,242
| -8% | -$237K | 0.88% | 37 |
|
|
2020
Q1 | $2.93M | Buy |
89,582
+740
| +0.8% | +$24.2K | 0.88% | 27 |
|
|
2019
Q4 | $3.48M | Buy |
+88,842
| New | +$3.48M | 0.94% | 23 |
|